Anti-obesity medications (AOMs) such as GLP-1s will play an unquestionable long-term role in balancing the “food trilemma”. But their advent may also have broad implications that alter public attitudes towards food and obesity.
Professional Planner is the leading voice for financial planners where they can learn about industry standards, get news, information, debate and develop new ideas.
We acknowledge the Traditional Custodians of this land upon which Conexus Financial sits, the Cadigal of the Eora Nation. We recognise their continuing connection and unique cultural and spiritual relationships to the land, waters and community. We pay our deepest respects to them and their culture, and to Elders both past and present.
Investor Insight